ProShare Advisors’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-10,724
| Closed | -$12.5K | – | 2150 |
|
|
2024
Q2 | $12.5K | Sell |
10,724
-2,938
| -22% | -$3.44K | ﹤0.01% | 1829 |
|
|
2024
Q1 | $124K | Buy |
13,662
+1,782
| +15% | +$16.1K | ﹤0.01% | 1786 |
|
|
2023
Q4 | $129K | Buy |
+11,880
| New | +$129K | ﹤0.01% | 1743 |
|
|
2022
Q2 | – | Sell |
-10,743
| Closed | -$100K | – | 2197 |
|
|
2022
Q1 | $100K | Sell |
10,743
-2,502
| -19% | -$23.3K | ﹤0.01% | 2033 |
|
|
2021
Q4 | $158K | Buy |
13,245
+665
| +5% | +$7.93K | ﹤0.01% | 2115 |
|
|
2021
Q3 | $143K | Sell |
12,580
-3,584
| -22% | -$40.7K | ﹤0.01% | 1854 |
|
|
2021
Q2 | $290K | Buy |
16,164
+3,448
| +27% | +$61.9K | ﹤0.01% | 1918 |
|
|
2021
Q1 | $197K | Buy |
12,716
+2,208
| +21% | +$34.2K | ﹤0.01% | 2049 |
|
|
2020
Q4 | $128K | Buy |
+10,508
| New | +$128K | ﹤0.01% | 1950 |
|
|
2020
Q3 | – | Sell |
-2,879
| Closed | -$29K | – | 1705 |
|
|
2020
Q2 | $29K | Buy |
+2,879
| New | +$29K | ﹤0.01% | 1648 |
|
|
2018
Q4 | – | Sell |
-5,245
| Closed | -$210K | – | 1731 |
|
|
2018
Q3 | $210K | Sell |
5,245
-211
| -4% | -$8.45K | ﹤0.01% | 1577 |
|
|
2018
Q2 | $154K | Buy |
5,456
+783
| +17% | +$22.1K | ﹤0.01% | 1666 |
|
|
2018
Q1 | $71K | Sell |
4,673
-773
| -14% | -$11.7K | ﹤0.01% | 1658 |
|
|
2017
Q4 | $178K | Buy |
+5,446
| New | +$178K | ﹤0.01% | 1665 |
|